Coventry University Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Dundee Featured PhD Programmes
University of Dundee Featured PhD Programmes
Life Science Zurich Graduate School Featured PhD Programmes

Investigation of the contribution of redox stress to the therapy resistance of cells experiencing cycling oxygen levels

Project Description

Hypoxia is a major barrier to successful cancer treatment as the more hypoxic a tumour, the less well patients respond. This project will focus on the physiologically relevant condition of cyclic hypoxia in which cancer cells experience fluctuations in oxygen levels as opposed to constant exposure to hypoxia. Recent findings from the Hammond lab suggest that the cellular response to cyclic hypoxia differs significantly from constant exposure and that this includes the contribution of changes in REDOX in the cyclic conditions. Understanding the dynamics of REDOX elements in biological systems is of major importance because of its roles in basic biology, agriculture, disease and medicine. However, quantifying changes in REDOX elements remains a major challenge for chemical biology. Key elements involved in defining the cellular REDOX environment include reactive oxygen species (ROS), reactive nitrogen species (RNS), sulfur-containing molecules including H2S and glutathione (GSH), hypoxia (lower than normal [O2]), and post-translational modification of amino acid residues in proteins. The relative concentration and interaction of these components defines the cellular REDOX environment, which is intrinsically linked to metabolism through processes such as glycolysis and oxidative phosphorylation. Cellular metabolism and REDOX state are in turn linked to epigenetic regulation, because modifications to chromatin involve consumption of important metabolites and REDOX-active molecules. Consequently, both metabolism and the REDOX environment can affect transcription through chromatin remodelling, and therefore cell fate decisions are closely linked to changes in metabolic activity and the REDOX environment. This project will investigate REDOX stress in cyclic hypoxia and how this contributes to biological response and sensitivity to cancer therapies. Specific approaches will include, for example, gene expression analysis (RNA-seq) of cells in both constant and cyclic hypoxia. This project will also benefit from early access to probes being generated in the Conway lab which will allow characterisation of REDOX stress.

This project offers unique access to a multi-disciplinary network of scientists brought together by the recently funded EPSRC programme grant led by Profs Conway and Hammond. The student will join this team and attend all programme meetings and will therefore interact with biologists, chemist and imaging scientists in a number of departments and indeed Universities (Kings College London is part of the programme). The student will be jointly supervised by Conway and Hammond and meet regularly (every 3 weeks) with both supervisors along with other members of the team. We (Conway and Hammond) have been collaborating for 10 years and have successfully graduated 4 DPhil students who have all had unprecedented training in chemical biology. Of these 4 students, 2 moved onto post doc positions, 1 has joined a small biotech company and the 4th is training in patent law

Design, synthesis and evaluation of molecularly targeted hypoxia-activated prodrugs. O’Connor LJ, Cazares-Körner C, Saha J, Evans CN, Stratford MR, Hammond EM, Conway SJ. Nature Protocols. 2016 Apr;11(4):781-94.

CH-01 is a hypoxia-activated prodrug that sensitizes cells to hypoxia/reoxygenation through inhibition of Chk1 and Aurora A. Cazares-Körner C, Pires IM, Swallow ID, Grayer SC, O’Connor LJ, Olcina MM, Christlieb M, Conway SJ, Hammond EM. ACS Chem Biol. 2013 Jul 19;8(7):1451-9.

Clinical Advances of Hypoxia-Activated Prodrugs in Combination with Radiation Therapy. Mistry IN, Thomas M, Calder EDD, Conway SJ, Hammond EM. Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1183-1196.

Funding Notes

All complete applications received by 12 noon (UK time) on Friday 11 January 2020 will automatically be considered for all relevant competitive University and funding opportunities, including the Clarendon Fund, Medical Research Council funding, and various College funds. Please refer to the Funding and Costs webpage (View Website) for this course for further details relating to funded scholarships and divisional funding opportunities.

Funded studentships are highly competitive and are awarded to the highest ranked applicant(s) based on the advertised entry requirements for each programme of study.


Whilst you must register three referees, the department may start the assessment of your application if two of the three references are submitted by the course deadline and your application is otherwise complete. Please note that you may still be required to ensure your third referee supplies a reference for consideration.

Academic references are strongly encouraged, though you may use up to one professional reference provided that it is relevant to the course.

How good is research at University of Oxford in Clinical Medicine?

FTE Category A staff submitted: 238.51

Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully

FindAPhD. Copyright 2005-2019
All rights reserved.